These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 8864715)

  • 1. European Pentoxifylline Multi-Infarct Dementia Study.
    Eur Neurol; 1996; 36(5):315-21. PubMed ID: 8864715
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rating scales and computed tomography in multi-infarct dementia.
    Folnegović-Smalc V; Mimica N; Makarić G; Loos V; Kittner B; Mimica N
    Neurol Croat; 1992; 41(4):183-90. PubMed ID: 1463803
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pentoxifylline in cerebrovascular dementia.
    Black RS; Barclay LL; Nolan KA; Thaler HT; Hardiman ST; Blass JP
    J Am Geriatr Soc; 1992 Mar; 40(3):237-44. PubMed ID: 1538042
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Scandinavian Multi-Infarct Dementia Trial: a double-blind, placebo-controlled trial on nimodipine in multi-infarct dementia.
    Pantoni L; Bianchi C; Beneke M; Inzitari D; Wallin A; Erkinjuntti T
    J Neurol Sci; 2000 Apr; 175(2):116-23. PubMed ID: 10831772
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Vascular-induced disorders of cerebral performance in the elderly. Long-term therapy with pentoxifylline and psychological mental training].
    Blume J; Rühlmann KU; de la Haye R; Rettig K; Oltmer G
    Fortschr Med; 1990 Nov; 108(33):638-42. PubMed ID: 2127040
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nicergoline in senile dementia of Alzheimer type and multi-infarct dementia: a double-blind, placebo-controlled, clinical and EEG/ERP mapping study.
    Saletu B; Paulus E; Linzmayer L; Anderer P; Semlitsch HV; Grünberger J; Wicke L; Neuhold A; Podreka I
    Psychopharmacology (Berl); 1995 Feb; 117(4):385-95. PubMed ID: 7604138
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A multicenter randomized double-blind study on the efficacy and safety of nicergoline in patients with multi-infarct dementia.
    Herrmann WM; Stephan K; Gaede K; Apeceche M
    Dement Geriatr Cogn Disord; 1997; 8(1):9-17. PubMed ID: 8997547
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A 12-month, randomized, placebo-controlled trial of propentofylline (HWA 285) in patients with dementia according to DSM III-R. The European Propentofylline Study Group.
    Marcusson J; Rother M; Kittner B; Rössner M; Smith RJ; Babic T; Folnegovic-Smalc V; Möller HJ; Labs KH
    Dement Geriatr Cogn Disord; 1997; 8(5):320-8. PubMed ID: 9298634
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Memantine in the treatment of mild to moderate dementia syndrome. A double-blind placebo-controlled study.
    Görtelmeyer R; Erbler H
    Arzneimittelforschung; 1992 Jul; 42(7):904-13. PubMed ID: 1418054
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Therapeutic efficacy of pyritinol in patients with senile dementia of the Alzheimer type (SDAT) and multi-infarct dementia (MID).
    Fischhof PK; Saletu B; Rüther E; Litschauer G; Möslinger-Gehmayr R; Herrmann WM
    Neuropsychobiology; 1992; 26(1-2):65-70. PubMed ID: 1475039
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Moving from the question of efficacy to the question of therapeutic relevance: an exploratory reanalysis of a controlled clinical study of 130 inpatients with dementia syndrome taking piracetam.
    Herrmann WM; Stephan K
    Int Psychogeriatr; 1992; 4(1):25-44. PubMed ID: 1391670
    [TBL] [Abstract][Full Text] [Related]  

  • 12. EEG mapping and psychopharmacological studies with denbufylline in SDAT and MID.
    Saletu B; Anderer P; Fischhof PK; Lorenz H; Barousch R; Böhmer F
    Biol Psychiatry; 1992 Oct; 32(8):668-81. PubMed ID: 1457622
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Therapeutic efficacy of vincamine in dementia.
    Fischhof PK; Möslinger-Gehmayr R; Herrmann WM; Friedmann A; Russmann DL
    Neuropsychobiology; 1996; 34(1):29-35. PubMed ID: 8884757
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Therapy of organic brain syndrome with nicergoline given once a day].
    Ladurner G; Erhart P; Erhart C; Scheiber V
    Wien Klin Wochenschr; 1991; 103(1):8-14. PubMed ID: 2014712
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The GBS scale in multi-infarct dementia and senile dementia of Alzheimer type.
    Olafsson K; Kørner A; Bille A; Jensen HV; Thiesen S; Andersen J
    Acta Psychiatr Scand; 1989 Jan; 79(1):94-7. PubMed ID: 2929386
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Paroxetine in the treatment of depression in geriatric patients--a double-blind comparative study with fluoxetine].
    Schöne W; Ludwig M
    Fortschr Neurol Psychiatr; 1994 Sep; 62 Suppl 1():16-8. PubMed ID: 7959520
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy and tolerability of memantine in patients with dementia syndrome. A double-blind, placebo controlled trial.
    Ditzler K
    Arzneimittelforschung; 1991 Aug; 41(8):773-80. PubMed ID: 1781796
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ginkgo biloba extract EGb 761 in dementia: intent-to-treat analyses of a 24-week, multi-center, double-blind, placebo-controlled, randomized trial.
    Kanowski S; Hoerr R
    Pharmacopsychiatry; 2003 Nov; 36(6):297-303. PubMed ID: 14663654
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of intravenous high dose co-dergocrine mesylate ('Hydergine') in elderly patients with severe multi-infarct dementia: a double-blind, placebo-controlled trial.
    Arrigo A; Casale R; Giorgi I; Guarnaschelli C; Zelaschi F
    Curr Med Res Opin; 1989; 11(8):491-500. PubMed ID: 2680286
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of chronic cerebrovascular disease in elderly patients with pentoxifylline.
    Blume J; Rùhlmann KU; de la Haye R; Rettig K
    J Med; 1992; 23(6):417-32. PubMed ID: 1293252
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.